We would love to hear your thoughts about our site and services, please take our survey here.
Badboxer - lets say your baby goes to ICU. Dr wants to prescribe antibiotics (as is the case 80,000 times a year in the UK). And you agree, and your baby goes deaf. How much is the care for that baby just increased by?
Cytiva, make and ship directly to supplier. Customer invoices go out same time as Cytiva invoices come in, natural hedge against low working capital scenarios (e.g. large orders that require procurement of raw materials.) That's not a concern.
So you take a PCR test, and two days later you get a result. In the intense waves that scenario hasn't lead people (e.g. health providers) to consider that those tested in that way remain negative. On Thursday they say, all I know is that you were negative on Tuesday. That's why there's such value (in multiple terms) in LFT and POC testing.
It's really interesting to consider how a PCR test might be used in that passport style scenario, to open up society - any thoughts? (It's perhaps not likely?).
I agree with much here (i probably moderate the positive and the negative)...
but I just wanted to add that the company, whether run well for SP or not, gets an awful lot of good value (in terms of product output) from it's R&D spend. Preventing hearing loss in babies is no small achievement! the TB and Hep C stuff is great. The Covid is full of uncertainty and that is a worry - but in reasonable market conditions where regulation happens on time and the Health Services have time to address all the issues (deaf babies, Hep C, TB), this company has a lot to offer. I'm not trying to ramp anything here - but I wont slam this thing either.
Brilliant Resource!
https://www.uktradeinfo.com/traders/genedrive-diagnostics-ltd-22612?senderQueryString=q%3Dgenedrive%26t%3DTraders%253a%253aname
Shows Exports of "Diagnostic Laboratory Reagents on a backing, prepared diagnostic or laboratory", sadly it does so pre-covid too.
January 2021 publication which is released on 12 March 2021. - so might be too soon!
Have a good look around before you conclude. E.g. see this note on data release schedule and ability it seems to be excluded to some degree. After march 12th, will also include data about exports to EU.
"
We will not publish:
national strategic and sensitive information, such as armaments exporters and their products
commercially sensitive information, for example where there are few exporters of a given product where actual levels of trade could be identified or deduced
details of markets, customers and market share
If you want your exporter information excluded, for whatever reason and at any time, contact uktradeinfo@hmrc.gov.uk providing your business name and VAT number.
Please note: a request to exclude your business from the exporter information sent to us by the day 15th of the month will mean removal from the information published the following month. For example, if you send in your request by 15 February 2021, we will make sure your information is not published in the January 2021 publication which is released on 12 March 2021.
However, this cannot apply retrospectively so we will not be able to remove information on exporter information already published.
"
https://www.divoc.health/covid19-testkits.html
They claim that is their list of covid tests.
and a google search of something like:
site:https://www.divoc.health, antigen
finds nothing.
I don't know what the truth is... I guess that's my point really.
Well, I am getting used the idea that the market is stupid.
That's for about 2 weeks. and they've opened another lab since then. So lets say that's 600k a month, * 2 (doubled labs) = 1.2M a month. *12 (months) = 14.4M Tests a year. *£5 (approx profit guess) .... £72 Million a year.... does that sound better.
Perhaps the market should do it's own research.
https://ted.europa.eu/udl?uri=TED:NOTICE:48653-2021:TEXT:EN:HTML&src=0
that one might help you too. It's a Biomek contract for 750k in the uk I thnk.
I might be wrong; I am busy!!